Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Ovid Therapeutics Inc | OVID | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.05 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.40 - 4.1389 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 3.05 | USD |
Ovid Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
215.67M | 70.71M | - | 1.5M | -54.17M | -0.77 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ovid Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OVID Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.99 | 3.38 | 2.95 | 3.09 | 292,038 | 0.06 | 2.01% |
1 Month | 3.50 | 3.5232 | 2.60 | 2.91 | 329,982 | -0.45 | -12.86% |
3 Months | 3.15 | 4.10 | 2.60 | 3.21 | 215,222 | -0.10 | -3.17% |
6 Months | 3.90 | 4.10 | 2.57 | 3.31 | 173,917 | -0.85 | -21.79% |
1 Year | 2.80 | 4.1389 | 2.40 | 3.47 | 196,306 | 0.25 | 8.93% |
3 Years | 3.93 | 4.80 | 1.405 | 3.41 | 244,640 | -0.88 | -22.39% |
5 Years | 1.81 | 10.45 | 1.405 | 3.95 | 661,420 | 1.24 | 68.51% |
Ovid Therapeutics Description
Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life. |